The Association between Systemic Immune-Inflammation Index and All-Cause Mortality in Acute Ischemic Stroke Patients: Analysis from the MIMIC-IV Database

Shaosheng Wu; Xiaoting Shi; Quan Zhou; Xiangjie Duan; Xiongfei Zhang; Huajing Guo

doi:10.1155/2022/4156489

The Association between Systemic Immune-Inflammation Index and All-Cause Mortality in Acute Ischemic Stroke Patients: Analysis from the MIMIC-IV Database

Emerg Med Int. 2022 Aug 2:2022:4156489. doi: 10.1155/2022/4156489. eCollection 2022.

Authors

Shaosheng Wu¹, Xiaoting Shi¹, Quan Zhou², Xiangjie Duan³, Xiongfei Zhang¹, Huajing Guo¹

Affiliations

¹ Department of Anesthesiology, First People's Hospital of Changde City, Changde, Hunan, China.
² Department of Science and Education Section, First People's Hospital of Changde City, Changde, Hunan, China.
³ Department of Infectious Diseases, First People's Hospital of Changde City, Changde, Hunan, China.

Abstract

Purpose: Acute ischemic stroke (AIS) is a devastating disease and remains the leading cause of death and disability. This retrospective study aims to investigate associations between systemic immune-inflammation index (SII) and all-cause mortality in patients with AIS. Patients and Methods. We used the data from Medical Information Mart for Intensive Care IV. A total of 1,181 patients with acute ischemic stroke (AIS) were included. Systemic immune-inflammation index (SII) was calculated as platelet count (/L) × neutrophil count (/L)/lymphocyte count (/L). The main outcomes were 30-day all-cause mortality. The association between SII with mortality was evaluated using the Cox proportional hazards regression model.

Results: After adjusting for potential covariates, the highest quartiles of SII versus the lowest quartiles of SII, the HR was 2.74 (CI 1.79-4.19, P < 0.001). Log-transformed SII was significantly associated with 30-day all-cause mortality (HR 2.44; CI 1.72-3.46, P < 0.001). Furthermore, we found that there is a nearly linear relationship (P=0.265) between logarithmic transformed SII with all-cause mortality.

Conclusion: Elevated SII of patients with acute ischemic stroke increased the risk of 30-day all-cause mortality. SII may serve as a useful marker to elucidate the role of thrombocytosis, inflammation, and immunity interaction in the development of AIS.